Metabolic Stack Retatrutide + Tesamorelin + MOTS-c · Research Peptide Stack — Canada
The Metabolic Stack combines Retatrutide, Tesamorelin and MOTS-c for metabolic research. Triple agonist, GHRH analogue and mitochondrial peptide.
Three different angles on metabolism: retatrutide works on the hormones that control appetite and blood sugar, tesamorelin on growth-hormone signalling and deep visceral fat, and MOTS-c on how cells sense and use energy.
$252.00 CAD ($15.00 less than buying separately, $267.00) — In stock. Flat $20.00 shipping, free over $300.00.
- Retatrutide 10mg — $89.00
- Tesamorelin 10mg — $89.00
- MOTS-c 40mg — $89.00
Reviewed 2026-11-08 by the Peak Peptides research team. 6 studies cited.
How they fit together
Hormone signals
Gut hormones that regulate appetite and blood sugar.
- Retatrutide: Activates the GLP-1, GIP and glucagon receptors at once.
Fat stores
Where the body keeps fat, especially deep visceral fat.
- Retatrutide: Body weight and liver fat in phase 2 and 3 trials.
- Tesamorelin: Visceral and liver fat in randomised trials.
Cell energy
How cells sense fuel and burn it.
- MOTS-c: AMPK energy sensing and PGC-1α in mouse models.
Insulin sensitivity
How well cells respond to insulin.
- Retatrutide: Glucose control in type 2 diabetes trials.
- MOTS-c: Insulin sensitivity and glucose handling in mouse models.
How they compare
| Compound | What it is | Pathway studied | Studied in | Evidence | Key study |
|---|---|---|---|---|---|
| Retatrutide | Triple-agonist peptide | GLP-1, GIP and glucagon receptors | Body weight, Glucose control, Liver fat | Phase 2 and 3 human trials | Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity. (2026), PMID 42814954 |
| Tesamorelin | GHRH analogue | GHRH receptor, growth hormone and IGF-1 | Visceral fat, Liver fat, GH signalling | Randomised human trials | Metabolic effects of a growth hormone-releasing factor in patients with HIV. (2007), PMID 18057338 |
| MOTS-c | 16-amino-acid mitochondrial peptide | AMPK energy sensing and PGC-1α | Insulin sensitivity, AMPK signalling, Exercise & ageing | Animal studies | The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. (2015), PMID 25738459 |
Key studies
- Retatrutide: Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity. (phase 3 trial, 2026). 80-week randomised trial in 2,339 adults with obesity.
- Retatrutide: Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial. (phase 2 trial, 2023). 48-week randomised trial in 338 adults.
- Tesamorelin: Metabolic effects of a growth hormone-releasing factor in patients with HIV. (phase 3 trial, 2007). 26-week randomised trial in 412 adults with HIV.
- Tesamorelin: Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial. (randomised trial, 2014). 6-month trial of visceral and liver fat in 50 adults.
- MOTS-c: The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. (discovery, 2015). First description of MOTS-c and its metabolic actions in mice.
- MOTS-c: MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. (preclinical, 2021). Physical capacity in young, middle-aged and old mice.
Related stacks
- GH Stack: Ipamorelin + Tesamorelin, $138.00 CAD
- Metabolic Stack · Ipamorelin: Retatrutide + Ipamorelin + MOTS-c, $222.00 CAD
- Recomp Stack: Retatrutide + Tesamorelin + Ipamorelin, $222.00 CAD
- Longevity Stack: NAD+ + MOTS-c + Epithalon, $252.00 CAD
Related research
- Retatrutide Canada Approval: TRIUMPH Phase 3 Results 2026
- Tesamorelin vs Ipamorelin vs Sermorelin: Receptors, Evidence and Regulatory Status Compared
- Do Peptides Cause Cancer? What the Research Actually Shows (2026)
Metabolic Stack, answered
What is the Metabolic Stack?
The Metabolic Stack combines Retatrutide, Tesamorelin and MOTS-c for metabolic research. Triple agonist, GHRH analogue and mitochondrial peptide.
Why are Retatrutide, Tesamorelin and MOTS-c researched together?
Three angles on metabolic research: retatrutide, the GLP-1/GIP/glucagon triple agonist; tesamorelin, studied for visceral and liver fat; and MOTS-c, a mitochondria-derived peptide studied through AMPK signalling.
How much does the Metabolic Stack cost?
The Metabolic Stack is $252.00 CAD, $15.00 less than buying Retatrutide, Tesamorelin and MOTS-c separately ($267.00). Shipping is a flat $20.00 across Canada, free on orders over $300.00.
Where can I buy the Metabolic Stack in Canada?
Peak Peptides ships the Metabolic Stack from Toronto to every province and territory, tracked and in discreet packaging. Orders paid before 12 PM (Toronto time) are dispatched the same day; delivery takes 1–3 business days in Ontario and 3–5 elsewhere in Canada.
What's the difference between the two Metabolic stacks?
They share retatrutide and MOTS-c. This one uses tesamorelin, a GHRH analogue; the Ipamorelin version uses ipamorelin, which works through the ghrelin receptor instead.
How is each compound tested?
Third-party tested, >98% purity, COA published. Each product page links the certificate of analysis for the current batch.
How is the Metabolic Stack supplied?
Each compound comes as a lyophilised powder in its own sealed vial, for laboratory research use only. Store at −20°C, dry and dark, and keep sealed and lyophilised until use.